Updated endometrial cancer FIGO staging: the role of MRI in determining newly included histopathological criteria
- 5 June 2024
- journal article
- research article
- Published by Springer Nature in Abdominal Radiology
- Vol. 49 (10) , 3711-3721
Abstract
Purpose Endometrial cancer (EC) is among the prevalent malignancies in gynecology, showing an increasing occurrence and mortality rate. The updated 2023 FIGO staging integrates both histopathological and molecular analyses, which significantly impact the prognosis and treatment approaches. This research aims to examine the effectiveness of MRI in identifying essential histopathological tumor features, including histological subtype, grade, and lymphovascular space invasion. Methods A total of 106 patients diagnosed with EC from February 2018 to December 2023 underwent preoperative pelvic MRI. Surgical procedures followed ESMO guidelines, with histopathological assessments using FIGO 2009 criteria. Two radiologists independently evaluated MRI images, measuring maximum tumor size, minimum tumor ADC value (using a free-hand ROI technique), and ADC tumor/myometrium ratio. MRI findings were compared with histopathological data. Results Peritoneal implant presence and tumor size exhibited significant differences between endometrioid adenocarcinoma (EAC) and non-endometrioid endometrial carcinoma (NEEC), with p values of < 0.001 and 0.003, respectively. Significant differences in age, tumor size, ADC tumor, and ADC tumor/myometrium between low-grade and high-grade tumors were observed, with p values of < 0.001, 0.004, 0.006, and 0.011, respectively. Increased tumor size, reduced ADC tumor, ADC tumor/myometrium, and pelvic peritoneal implant presence were significantly associated with LVSI, with p values of < 0.001, 0.001, 0.002, and 0.001, respectively. The AUC values for tumor size, ADC tumor, and ADC tumor/myometrium were 0.842, 0.781 and 0.747, respectively, in distinguishing between low and high-grade endometrial tumors. Similarly, obtained AUC values for predicting LVSI were 0.836, 0.719, and 0.696, respectively. Conclusion Our study emphasizes MRI’s role in predicting tumor characteristics such as histological subtype, grade, and LVSI based on updated FIGO criteria. By highlighting the potential of MRI, this research contributes to our comprehension of improving diagnostic and clinical management for EC. Further multicenter studies are warranted to validate these findings and establish MRI’s role in EC management.Keywords
This publication has 31 references indexed in Scilit:
- Endometrial Carcinoma: MR Imaging–based Texture Model for Preoperative Risk Stratification—A Preliminary AnalysisRadiology, 2017
- Agreement Between Preoperative Endometrial Sampling and Surgical Specimen Findings in Endometrial CarcinomaInternational Journal of Gynecological Cancer, 2017
- Preoperative diagnosis of tumor grade and type in endometrial cancer by pipelle sampling and hysteroscopy: Results of a French studySurgical Oncology, 2016
- Role of diffusion-weighted MRI in the differential diagnosis of endometrioid and non-endometrioid cancer of the uterusActa Radiologica, 2016
- Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC CohortsClinical Cancer Research, 2016
- Practical issues in the diagnosis of serous carcinoma of the endometriumLaboratory Investigation, 2016
- Diffusion-weighted imaging in the assessment of tumour grade in endometrial cancerBritish Journal of Radiology, 2011
- Endometrial Cancer: Correlation of Apparent Diffusion Coefficient With Tumor Grade, Depth of Myometrial Invasion, and Presence of Lymph Node MetastasesAmerican Journal of Roentgenology, 2011
- Carcinoma of the Corpus UteriInternational Journal of Gynecology & Obstetrics, 2006
- The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiationGynecologic Oncology, 2006